Skip to content
healthcare.dev

Lidocaine Hydrochloride and Hydrocortisone Acetate

NDC 13925-164, Lidocaine Hydrochloride and Hydrocortisone Acetate, gel, from Seton Pharmaceuticals.

Product NDC
13925-164
Status
Listed
Labeler
Seton Pharmaceuticals
Dosage form
GEL
Route
RECTAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13925-164 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIDOCAINE HYDROCHLORIDE30 mg/g
  • HYDROCORTISONE ACETATE25 mg/g

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
13925-164-201392501642020 TUBE in 1 KIT (13925-164-20) / 7 g in 1 TUBE (13925-164-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fd6343a9-15a6-4894-b51f-122e4d6dbe79

Use it

Look up 13925-164 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13925-164 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13925-164. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.